Modeling of hepatitis B virus kinetics and accumulation of cccDNA in primary human hepatocytes

Using primary human hepatocytes (PHHs), we characterize early HBV kinetics post infection. HBV-infected PHH were treated with an entry inhibitor to characterize the accumulation of intracellular and extracellular HBV DNA and the nuclear episomal viral genome called covalently closed circular DNA (cccDNA) in the absence of HBV spread. Kinetic and mathematical modeling in PHHs confirms that the replication inhibitor, entecavir, strongly blocks intracellular HBV DNA accumulation, which also slowed the accumulation of cccDNA. However, modeling indicates that effects on cccDNA accumulation are not directly determined by intracellular HBV DNA levels, supporting the conclusion that cccDNA levels within the cell are regulated in some yet-to-be-elucidated manner.

Authors

Institutions

Publication Details

Journal
JHEP Reports
Published
2024-12-24
DOI
https://doi.org/10.1016/j.jhepr.2024.101311
Citations
6
Primary Topic
Hepatitis B Virus Studies
Type
article
Field-Weighted Citation Impact
2.32

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Modeling of hepatitis B virus kinetics and accumulation of cccDNA in primary human hepatocytes

Chise Tateno, Kazuaki Chayama, Masataka Tsuge, Harel Dahari et al.
6 citations
JHEP Reports
Hepatitis B Virus Studies
2.32
article

Modeling of hepatitis B virus kinetics and accumulation of cccDNA in primary human hepatocytes

Chise Tateno, Kazuaki Chayama, Masataka Tsuge, Harel Dahari, Yuji Ishida, Susan L. Uprichard, Masaki Takahashi, Vladimir Reinharz, Louis Shekhtman, Mikaru Yamao
article en
6 citations

Abstract

Using primary human hepatocytes (PHHs), we characterize early HBV kinetics post infection. HBV-infected PHH were treated with an entry inhibitor to characterize the accumulation of intracellular and extracellular HBV DNA and the nuclear episomal viral genome called covalently closed circular DNA (cccDNA) in the absence of HBV spread. Kinetic and mathematical modeling in PHHs confirms that the replication inhibitor, entecavir, strongly blocks intracellular HBV DNA accumulation, which also slowed the accumulation of cccDNA. However, modeling indicates that effects on cccDNA accumulation are not directly determined by intracellular HBV DNA levels, supporting the conclusion that cccDNA levels within the cell are regulated in some yet-to-be-elucidated manner.

JHEP ReportsVol. 7(4)
Hiroshima University (JP), Loyola University Medical Center (US), Bar-Ilan University (IL), Université du Québec à Montréal (CA), PhoenixBio (Japan) (JP), Hiroshima University Hospital (JP), RIKEN Center for Integrative Medical Sciences (JP)
Japan Agency for Medical Research and Development, National Institutes of Health, Japan Society for the Promotion of Science
Good health and well-being
Openalex Percentile: Top 10%
Hepatitis B Virus Studies
2.32
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Modeling of hepatitis B virus kinetics and accumulation of cccDNA in primary human hepatocytes — Chise Tateno, Kazuaki Chayama, et al. · JHEP Reports (2024) | TGRS Research Map | TGRS